FDA Approves Prevacid 24HR for OTC Market

Novartis here announced last week it won over-the-counter approval from the U.S. Food and Drug Administration for Proton Pump Inhibitor Prevacid 24HR (lansoprazole delayed-release capsules 15 mg).

BASEL, Switzerland — Novartis here announced last week it won over-the-counter approval from the U.S. Food and Drug Administration for Proton Pump Inhibitor Prevacid 24HR (lansoprazole delayed-release capsules 15 mg).

Register to view the full article